|
Showing the most relevant articles for your search:NYSE:ELN | Date | Time | Source | Headline | Symbol | Company | | 05/23/2013 | 8:32AM | Dow Jones News | Royalty Pharma Lowers Acceptance Threshold For Elan Offer | NYSE:ELN | Elan Corp., Plc Adr |
| 05/23/2013 | 6:31AM | PR Newswire (US) | Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share | NYSE:ELN | Elan Corp., Plc Adr |
| 05/21/2013 | 5:16PM | Zacks | Elan Provides Strategic Update - Analyst Blog | NYSE:ELN | Elan Corp., Plc Adr |
| 05/21/2013 | 1:45PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NYSE:ELN | Elan Corp., Plc Adr |
| 05/20/2013 | 5:23PM | Edgar (US Regulatory) | Report of Foreign Issuer (6-k) | NYSE:ELN | Elan Corp., Plc Adr |
| 05/20/2013 | 5:14PM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NYSE:ELN | Elan Corp., Plc Adr |
| 05/20/2013 | 5:06PM | Edgar (US Regulatory) | Report of Foreign Issuer (6-k) | NYSE:ELN | Elan Corp., Plc Adr |
| 05/20/2013 | 3:30PM | Dow Jones News | Royalty Pharma Raises Takeover Bid for Elan | NYSE:ELN | Elan Corp., Plc Adr |
| 05/20/2013 | 1:00PM | Business Wire | Elan’s Response to Royalty Pharma Announcement | NYSE:ELN | Elan Corp., Plc Adr |
| 05/20/2013 | 11:44AM | PR Newswire (US) | Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash | NYSE:ELN | Elan Corp., Plc Adr |
| 05/20/2013 | 8:53AM | Edgar (US Regulatory) | Report of Foreign Issuer (6-k) | NYSE:ELN | Elan Corp., Plc Adr |
| 05/20/2013 | 6:30AM | Dow Jones News | Elan Sets Out Deal Plans | NYSE:ELN | Elan Corp., Plc Adr |
| 05/20/2013 | 2:00AM | Business Wire | Elan Announces Transactions: Decisively Transforming the Company | NYSE:ELN | Elan Corp., Plc Adr |
| 05/20/2013 | 2:00AM | Business Wire | Elan Announces Proposed Offering of US$800.0 Million in Aggregate Principal Amount of Senior Notes Due 2021 | NYSE:ELN | Elan Corp., Plc Adr |
| 05/17/2013 | 6:03AM | Edgar (US Regulatory) | Report of Foreign Issuer (6-k) | NYSE:ELN | Elan Corp., Plc Adr |
| 05/15/2013 | 5:24PM | Edgar (US Regulatory) | Report of Foreign Issuer (6-k) | NYSE:ELN | Elan Corp., Plc Adr |
| 05/15/2013 | 5:14PM | Business Wire | Elan Announces Publication of Response Document | NYSE:ELN | Elan Corp., Plc Adr |
| 05/15/2013 | 5:06PM | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NYSE:ELN | Elan Corp., Plc Adr |
| 05/14/2013 | 12:30PM | Zacks | Elan in Royalty Deal with THRX - Analyst Blog | NYSE:ELN | Elan Corp., Plc Adr |
| 05/14/2013 | 5:12AM | Zacks | Spectrum Pharma Reports 1Q Loss - Analyst Blog | NYSE:ELN | Elan Corp., Plc Adr |
| 05/13/2013 | 5:12PM | Edgar (US Regulatory) | Report of Foreign Issuer (6-k) | NYSE:ELN | Elan Corp., Plc Adr |
| 05/13/2013 | 4:55PM | Edgar (US Regulatory) | Report of Foreign Issuer (6-k) | NYSE:ELN | Elan Corp., Plc Adr |
| 05/13/2013 | 9:13AM | Dow Jones News | U.S. HOT STOCKS FUTURES: HOT STOCKS TO WATCH | NYSE:ELN | Elan Corp., Plc Adr |
| 05/13/2013 | 6:00AM | Dow Jones News | Elan Signs $1 Billion Drug Deal | NYSE:ELN | Elan Corp., Plc Adr |
| 05/13/2013 | 2:49AM | Dow Jones News | Elan, Theravance Enter Into $1.0 Billion Royalty Participation Pact | NYSE:ELN | Elan Corp., Plc Adr |
| 05/13/2013 | 2:03AM | Business Wire | Elan Provides Additional Commentary on Elan/Theravance Royalty Participation Agreement | NYSE:ELN | Elan Corp., Plc Adr |
| 05/13/2013 | 2:02AM | Business Wire | Theravance and Elan Enter Into a $1.0 Billion Royalty Participation Agreement | NYSE:ELN | Elan Corp., Plc Adr |
| 05/13/2013 | 2:00AM | Marketwired | Theravance and Elan Enter Into a $1.0 Billion Royalty Participation Agreement | NYSE:ELN | Elan Corp., Plc Adr |
| 05/10/2013 | 5:49AM | Zacks | Dendreon Narrows 1Q Loss - Analyst Blog | NYSE:ELN | Elan Corp., Plc Adr |
| 05/08/2013 | 12:09PM | Zacks | Santarus Beats on Earnings and Revs - Analyst Blog | NYSE:ELN | Elan Corp., Plc Adr |
|
Showing the most relevant articles for your search:NYSE:ELN |
|